AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company advancing novel small molecule therapeutics derived from ...
Mycobacterium abscessus can cause dangerous lung infections. Treatment usually requires a combination of antibiotics for more than a year. Researchers in China report that curcumin, found in turmeric, ...
A new single cell-based screening tool evaluates how well antibiotics kill bacteria and may help researchers determine which ...
GARDEN CITY, N.Y., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for ...
Mycobacterium abscessus bacteria most often infect the lungs of people with cystic fibrosis, bronchiectasis or other chronic lung diseases. The infection causes scarring, thickening of tissue or ...
At the center of this resistance is the WhiB7 “resistome,” a set of antibiotic-limiting genes in M. abscessus. “WhiB7 is a master regulator of ribosomal stress, and many antibiotics used to treat ...
Scientists from Johns Hopkins University and Medicine have developed a possible new antibiotic for a pathogen that is notoriously resistant to medications and frequently lethal for people with cystic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback